Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Regulation of the error-prone DNA polymerase polκ by oncogenic signaling and its contribution to drug resistance

ABSTRACT: We report how the A375 melanoma cell line changes following CRISPR-Cas9 inactivation of POLK

ORGANISM(S): Homo sapiens

PROVIDER: GSE145313 | GEO | 2020/02/15

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Regulation of the error-prone DNA polymerase Polκ by oncogenic signaling and its contribution to drug resistance.

Project description: Not available

| S-EPMC7428051 | biostudies-literature

Catestatin impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways

Project description:Melanoma remains one of the most aggressive and treatment-resistant cancers, emphasizing the need for novel therapeutics. In our current study we report a peptide-based approach as potential therapeutic. The expression and role of Catestatin(CST), a Chromogranin A(CgA)-derived peptide with immunomodulatory and reparative properties in skin injury led us to examine its connection to melanoma. Advancing melanoma stages showed decreased CST expression. CST administration to patient derived cells and melanoma cell lines A375, B16F10, SKMEL28 revealed increased apoptosis, decreased proliferation and metastatic ability of the melanoma cells without affecting cell viability for normal skin fibroblasts. CST reduced growth kinetics and tumor weight in B16F10 derived in vivo melanoma tumors. Transcriptomic analyses of catestatin treated human cell line and mouse tumor revealed downregulation of hypoxia, collagen remodeling, epithelial to mesenchymal transition pathways (EMT), stress adaptive responses that are accountable for melanoma progression. In Vemurafenib-resistant A375 cells, CST increased apoptosis and repressed multiple resistance associated genes. These results highlight CST as a promising therapeutic candidate capable of opposing melanoma progression and overcoming resistance to current targeted treatments.

2026-03-16 | GSE312638 | GEO

Regulation of the error-prone DNA polymerase polκ by oncogenic signaling and its contribution to drug resistance

Project description:Regulation of the error-prone DNA polymerase polκ by oncogenic signaling and its contribution to drug resistance

| PRJNA606746 | ENA

Cancer genes disfavoring T cell immunity identified via integrated systems approach

Project description:A375 melanoma cells were transduced with Cas9 and non-targeting (NT) or BIRC2-targeting sgRNAs. Cells were cultured for 20 days post gene-editing and cell pellets were collected for analysis. Separately, A375 melanoma cells were treated with LCL161 for 16 hours and cell pellets were collected for analysis.

2022-06-27 | MSV000089737 | MassIVE

poliota, a remarkably error-prone human DNA polymerase.

Project description: Not available

| S-EPMC316739 | biostudies-literature

poliota, a remarkably error-prone human DNA polymerase.

Project description: Not available

| S-EPMC316739 | biostudies-literature

Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals.

Project description: Not available

| S-EPMC2646147 | biostudies-literature

Comparative gene expression profiles of NOS1-KO and WT A375 melanoma cell lines

Project description:NOS1 plays a vital role in tumor. A cell model of NOS1 gene knockout in human melanoma cell line A375 was constructed using CRISPR/Cas9 technique for the study of its function. We used microarrays to detail the Global gene expression underlying NOS1-knockout compare to wild type A375 cell.

2021-12-31 | GSE166287 | GEO

The putative error prone polymerase <i>REV1</i> mediates DNA damage and drug resistance in <i>Candida albicans</i>.

Project description: Not available

| S-EPMC11606924 | biostudies-literature

INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq]

Project description:Super-enhancers (SEs) are large genomic regions with high density of enhancer marks. In cancer, SEs are found near oncogenes and dictate cancer gene expression. However, how oncogenic SEs are regulated remains poorly understood. Here, we show that INO80, a chromatin remodeling complex, is required for SE-mediated oncogenic transcription and tumor growth in melanoma. The expression of Ino80, the SWI/SNF ATPase, is elevated in melanoma cells and patient melanomas compared to normal melanocytes and benign nevi. Furthermore, Ino80 silencing selectively inhibits melanoma cell proliferation, anchorage-independent growth, as well as tumorigenesis and tumor maintenance in mouse xenografts. Mechanistically, Ino80 occupies more than 90% of SEs, and its occupancy is dependent on transcription factors such as MITF and Sox9. Ino80 binding reduces nucleosome occupancy and facilitates Mediator recruitment, thus promoting oncogenic transcription. Consistently, genes co-occupied by Ino80 and Med1 are specifically expressed in melanomas compared to melanocytes. Together, our results reveal an essential role of INO80-dependent chromatin remodeling in SE function, and suggest a novel strategy for disrupting SEs in cancer treatment. Human melanoma cell line A375 cells were infected with shNT or shIno80, and total RNA was extracted 2, 3, 4 days after infection. The RNA was submitted to RNA-Seq subsequently. For ChIP-Seq, either wild type A375 and SK-MEL-147, or A375 infected with shNT or shIno80, was used for ChIP-Seq for corresponding factors.

2016-07-07 | E-GEOD-82333 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data